X @Bloomberg
Bloomberg·2025-11-03 20:44
Tylenol-maker Kenvue’s sale to Kimberly-Clark is a $40 billion gamble — but one with decent odds, says @hughes_chris (via @opinion) https://t.co/V0E3LBEA3E ...
Tylenol-maker Kenvue’s sale to Kimberly-Clark is a $40 billion gamble — but one with decent odds, says @hughes_chris (via @opinion) https://t.co/V0E3LBEA3E ...